Amgen
AMGN
2,716 hedge funds and large institutions have $117B invested in Amgen in 2024 Q1 according to their latest regulatory filings, with 187 funds opening new positions, 1,128 increasing their positions, 1,020 reducing their positions, and 148 closing their positions.
26% more first-time investments, than exits
New positions opened: 187 | Existing positions closed: 148
11% more repeat investments, than reductions
Existing positions increased: 1,128 | Existing positions reduced: 1,020
6% more call options, than puts
Call options by funds: $2.28B | Put options by funds: $2.14B
0% more funds holding
Funds holding: 2,715 → 2,716 (+1)
5% less capital invested
Capital invested by funds: $123B → $117B (-$5.56B)
2.53% less ownership
Funds ownership: 79.53% → 77% (-2.5%)
30% less funds holding in top 10
Funds holding in top 10: 79 → 55 (-24)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.73B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$891M |
| 3 |
Barclays
London,
United Kingdom
|
+$417M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$403M |
| 5 |
CWP
Capital Wealth Planning
Naples,
Florida
|
+$243M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.36B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1B |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$303M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$267M |
| 5 |
Two Sigma Advisers
New York
|
-$237M |
AMGN Hedge Fund Activity: Q1 2024 in Review
2,716 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2024, worth a combined $117B — down 4.5% from $123B a quarter earlier.
Buyers outnumbered sellers: 187 funds opened new AMGN positions and 148 closed out — a net gain of 39 holders — while 1,128 added to existing stakes and 1,020 trimmed.
The largest buyer was Capital International Investors, adding an estimated $1.73B. The largest seller was Morgan Stanley, cutting an estimated $4.36B.
- 2,716 institutional investors held Amgen (AMGN) as of Q1 2024, up from 2,715 in Q4 2023.
- Funds reported $117B of Amgen stock for Q1 2024, down 4.5% quarter-over-quarter.
- 187 funds opened new Amgen positions in Q1 2024 and 148 closed out, a net change of +39 holders.
- The largest Amgen buyer in Q1 2024 was Capital International Investors, an estimated $1.73B added.
- The largest Amgen seller in Q1 2024 was Morgan Stanley, an estimated $4.36B sold.
Based on aggregated 13F filings for Q1 2024.